Wave Life Sciences to Webcast Conference Call of Second Quarter 2021 Financial Results on August 5, 2021
July 26 2021 - 4:05PM
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage
genetic medicines company committed to delivering life-changing
treatments for people battling devastating diseases, announced
today that management will host a live webcast and conference call
at 8:30 a.m. ET on Thursday, August 5, 2021, to
discuss its second quarter 2021 financial results and provide a
business update.
The webcast of the conference call may be accessed by visiting
the “Events” section in the Investor Relations page of
the Wave Life Sciences website
at www.wavelifesciences.com. The live teleconference may be
accessed by dialing (800) 708-4540 (domestic) or (847) 619-6397
(international) and entering conference ID: 50197439. Following the
conference call, an archived version of the call will be available
on the website.
About Wave Life SciencesWave Life
Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines
company committed to delivering life-changing treatments for people
battling devastating diseases. Wave aspires to develop
best-in-class medicines across multiple therapeutic modalities
using PRISM, the company’s proprietary discovery and drug
development platform that enables the precise design, optimization,
and production of stereopure oligonucleotides. Driven by a resolute
sense of urgency, the Wave team is targeting a broad range of
genetically defined diseases so that patients and families may
realize a brighter future. To find out more, please
visit www.wavelifesciences.com and follow Wave on Twitter
@WaveLifeSci.
Investor Contact:Kate
Rausch617-949-4827krausch@wavelifesci.com
Media Contact:Alicia
Suter617-949-4817asuter@wavelifesci.com
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Apr 2023 to Apr 2024